Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST
Cue Biopharma Employees
Cue Biopharma had 29 employees as of December 31, 2025. The number of employees decreased by 12 or 29.27% compared to the previous year. That makes Cue Biopharma the 37,238th largest employer in the world and 5,166th in the United States.
Employees
29
Change (1Y)
-12
Growth (1Y)
-29.27%
Revenue / Employee
$1,228,897
Profits / Employee
-$7,126,759
Market Cap
32.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | -12 | -29.27% | 29 | 0 |
| Dec 31, 2024 | 41 | -12 | -22.64% | 41 | 0 |
| Dec 31, 2023 | 53 | 1 | 1.92% | 53 | 0 |
| Dec 31, 2022 | 52 | -7 | -11.86% | 51 | 1 |
| Dec 31, 2021 | 59 | 7 | 13.46% | 57 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| IGC Pharma | 70 |
| BeyondSpring | 44 |
| Atossa Therapeutics | 16 |
| CervoMed | 15 |
| Lipocine | 14 |
| Cocrystal Pharma | 10 |
CUE News
- 1 day ago - Cue Biopharma price target lowered to $25 from $83 at B. Riley - TheFly
- 1 day ago - Cue selloff brings âattractive buying opportunity,â says Lucid Capital - TheFly
- 2 days ago - Cue Biopharma trading resumes - TheFly
- 2 days ago - Cue Biopharma trading halted, volatility trading pause - TheFly
- 3 days ago - Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 days ago - Cue Biopharma Quarterly report: Q3 2026 - Filings
- 3 days ago - Cue Biopharma Earnings release: Q3 2026 - Filings
- 1 month ago - B. Riley would be âaggressive buyersâ of Cue Biopharma after selloff - TheFly